Application Of High-Speed ​​Centrifugal Spray Dryers In The Pharmaceutical Industry

The spray dryer operates on an open-cycle, co-current flow principle using centrifugal atomization. Air (the drying medium) passes through primary and medium-efficiency filters; drawn by a blower according to operating instructions, it is heated and then enters the main drying tower via a hot-air distributor equipped with a high-efficiency filter. Liquid material is fed via a peristaltic pump into a high-speed rotating centrifugal atomizer, where centrifugal force disperses it into fine droplets. Inside the main tower, these droplets make full contact with the hot air; after undergoing heat exchange along a specific path, they dry into the final product. Separation is achieved via a cyclone separator, where solid material is collected and the exhaust gas is filtered before discharge. The entire system is easy to clean, free of dead zones, and compliant with GMP requirements.

Pharmaceutical production is a primary application area; the critical nature of medicines and the diverse properties of pharmaceutical materials necessitate specific production standards. GMP (Good Manufacturing Practice) has become a mandatory system and regulation in pharmaceutical manufacturing, encompassing design, fabrication, installation, operation, management, and validation. Whether chemically synthesized drugs, biological products, or plant- and nature-derived medicines, pharmaceutical materials are often highly heat-sensitive. They require lower hot-air temperatures and possess complex compositions—particularly plant-based drugs, which vary significantly in material properties. Characteristics such as high polypeptide, polysaccharide, and protein content, strong hygroscopicity, high viscosity, low softening points, and the need to preserve active ingredients without degradation place stringent demands on pharmaceutical drying equipment. A pharmaceutical spray dryer is a device that atomizes liquid material into fine particles and brings them into contact with hot air within a drying chamber, causing rapid moisture evaporation and directly yielding a powdered product. I. This type of equipment offers the following performance characteristics:

1. During the drying process, the temperature of the droplets remains low, minimizing thermal impact on the product. This prevents issues such as protein denaturation or the loss and oxidation of vitamins and active ingredients; for heat-sensitive materials, biological products, and pharmaceuticals, the quality achieved is essentially comparable to that of vacuum drying.

2. Powdered products can be obtained directly from liquid raw materials. Generally, the D50 particle size for high-speed centrifugal spray drying ranges from 60 to 125 μm (approx. 250–120 mesh), while for pressure spray drying, it ranges from 125 to 250 μm (approx. 120–60 mesh).

3. The drying time is very short, typically requiring only 5 to 40 seconds.

4. The product largely retains a spherical shape similar to the original droplets, offering excellent dispersibility, flowability, and solubility.

5. By adjusting parameters such as the liquid feed's moisture content or spray drying conditions, one can control the product's residual moisture, particle size, and bulk density within specific ranges; this simplifies the production process and facilitates convenient control and management.

Due to these characteristics, the application of spray drying in the pharmaceutical industry is expanding rapidly. Based on the features of pharmaceutical spray dryers, material properties, and GMP equipment requirements, an open-cycle, vertical downward co-current flow configuration is generally recommended for most materials—specifically, a high-speed centrifugal rotary atomizer spray dryer is preferred, particularly for Traditional Chinese Medicine (TCM) applications. If a particle size coarser than 100 mesh (150 μm) is required, a pressure nozzle spray dryer may be selected.

II. Basic functions required for pharmaceutical spray dryers:

1. To ensure exhaust emissions meet environmental standards, a two-stage dust removal system should be considered: the first stage utilizes a high-efficiency cyclone separator for dry powder recovery, while the second stage employs a dry bag filter or wet dust collector to recover residual fine powder. For dryers handling highly hygroscopic products or multiple product varieties, a wet dust collector is more suitable. 2. To prevent contamination of the dried product, all parts in contact with the material or hot air must be made of stainless steel; the specific grade of stainless steel used must be compatible with the pH requirements of the pharmaceutical material.

3. To meet hygiene standards, air entering the tower must undergo sterilization filtration. Regarding cleanliness levels, Class 100 standards should be considered for injectable products, while Class 100,000 to 300,000 standards are acceptable for other products. The drying tower must operate under slight positive pressure. The finished product is discharged from the lower conical section of the tower, with collection and packaging taking place in a cleanroom environment.

4. The equipment features excellent sealing, smooth and even interior surfaces, and a simplified structure; it is designed for easy disassembly, cleaning, and stable operation.